结合三个外周血液生物标志物来分层类型的风湿性关节炎 - 相关的间歇性肺部疾病风险风险
Kelsey Coziahr1, Austin M Wheeler1, Brent A Luedders1
1VA Nebraska-Western Iowa Health Care System & University of Nebraska Medical Center, Omaha, NE.
Arthritis care & research
|December 15, 2025
概括
一个新的三分析生物标志物得分有助于风湿性关节炎相关间歇性肺病 (RA-ILD) 的风险分层. 这一得分,结合MUC5B变异,MMP-7和抗MAA抗体水平,显示出有可能识别患RA-ILD风险的患者.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 生物标志物发现发现
背景情况:
- 类风湿性关节炎相关的间歇性肺病 (RA-ILD) 是类风湿性关节炎 (RA) 的重要并发症.
- 准确的RA-ILD风险分层对于及时干预和管理至关重要.
- 当前的风险评估模型可能无法完全捕捉个体患者的风险.
研究的目的:
- 评估一种新的生物标志物评分,用于分层分布和发生RA-ILD的风险.
- 这一分数包括MUC5B rs35705950促进体变异,血矩阵金属蛋白酶 (MMP) -7,以及血清抗马隆迪甲酸 (anti-MAA) 抗体.
主要方法:
- 对美国老兵进行了多中心队列研究,包括对流行RA-ILD的横截面分析和对事件RA-ILD的队列研究.
- 根据MUC5B变异的存在和MMP-7和抗MAA抗体水平的升高,计算了三种分析生物标志物得分 (0-3).
- 使用多变量后勤和考克斯回归模型,并根据临床风险因素进行调整.
主要成果:
- 在2043名RA参与者中,较高的生物标志物得分与流行RA-ILD的几率增加有关 (aOR为3比0的12.21).
- 3的得分也表明发生RA-ILD的风险最高 (aHR4.36).
- 将生物标志物得分与临床因素相结合,改善了对流行和发病RA-ILD的风险预测.
结论:
- 评估的三种分析生物标志物得分表明与流行和事件RA-ILD相关.
- 这一分数增强了风险分层,超出了传统的临床因素.
- 虽然尚未准备好临床实施,但这些发现突出了RA-ILD风险评估生物标志物评分的潜力.
更多相关视频
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
443
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
443
Rheumatic Heart Disease I: Introduction
407
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
407
Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
Rheumatic Heart Disease III: Medical Management
264
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
264
Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K


